Gracecast Lung Cancer Audio
- Author: Vários
- Narrator: Vários
- Publisher: Podcast
- Duration: 35:44:44
- More information
Informações:
Synopsis
Oncology experts summarize current and emerging issues in cancer management for patients and caregivers. Information from the Global Resource for Advancing Cancer Education (GRACE) helps people to become informed partners in their care.
Episodes
-
ASCO 2012 LC Highlights: Dr. Mark Socinski on Single Agent vs Doublet Chemo for PS2 (audio)
19/08/2012 Duration: 06minDr. Mark Socinski from the University of Pittsburgh reviews evidence to support doublet chemo over single agent for marginal performance status (PS2) patients with advanced NSCLC.
-
ASCO 2012 Lung Cancer Highlights: Dr. Mark Socinski on PARAMOUNT Continuation Maintenance Therapy Trial (audio)
16/08/2012 Duration: 08minDr. Mark Socinski from the University of Pittsburgh reviews the survival benefit and implications from the PARAMOUNT maintenance therapy trial of Alimta (pemetrexed) in advanced NSCLC.
-
Immunotherapy for Lung Cancer: Q and A Session (audio)
16/07/2012 Duration: 13minDrs. Ramaswamy Govindan from Washington University and Julie Brahmer from Johns Hopkins University answer questions about the current evidence and emerging research on immune-based treatments for lung cancer.
-
Immunotherapy for Lung Cancer: Yervoy, anti-PD-1, Reolysin, & Talactoferrin by Dr. J. Brahmer (audio)
14/06/2012 Duration: 23minDr. Julie Brahmer reviews science and early trial results for immunotherapies for lung cancer ranging from cancer vaccines to anti-cancer viruses.
-
Immunotherapies for Lung Cancer: MAGE-A3, Stimuvax, and Lucanix, by Dr. R. Govindan (audio)
07/06/2012 Duration: 21minDr. Ramaswamy Govindan provides a summary of the science behind several promising immunotherapies for lung cancer and the clinical trials that could lead to them being integrated into our treatment plans.
-
Molecular Markers in Lung Cancer Pt 6: Dr. Glen Goss on Incorporating Markers Across a Health Care System (audio)
23/05/2012 Duration: 25minDr. Glen Goss, University of Ottawa and NCI-Canada Lung Cancer Committee chair, discusses the potential and limitations of integrating molecular marker studies in advanced non-small cell lung cancer patients across a health care system.
-
Molecular Markers in Lung Cancer Pt 5: Dr. David Spigel on Incorporating Targets into Clinical Trials (audio)
10/05/2012 Duration: 24minDr. David Spigel, Sarah Cannon Cancer Center, discusses the benefits and challenges of conducting trials that include patient subgroups based on molecular markers.
-
Molecular Markers in Lung Cancer Pt 4: Broadening Use of Markers in Practice -- Panel Discussion (audio)
28/04/2012 Duration: 16minPanel discussion with 4 expert thought leaders in lung cancer about how we might best approach testing clinically relevant molecular targets in lung cancer patients.
-
Molecular Markers in Lung Cancer Pt 3: Who to Test and What to Test For -- Panel Discussion (audio)
23/04/2012 Duration: 17minPanel discussion with 4 expert thought leaders in lung cancer about the prevalence of critical molecular markers in different clinical and histologic groups of lung cancer patients.
-
Molecular Markers in Lung Cancer Pt 2: Dr. Alice Shaw on Mutation Patterns by Patient Features (audio)
14/04/2012 Duration: 10minDr. Alice Shaw from Massachusetts General Hospital reviews the frequency of molecular markers in lung cancer by patient sex, smoking status, race, and histology.
-
Molecular Markers in Lung Cancer Pt 1: Dr. Charles Rudin on The Lung Cancer Mutation Consortium (audio)
06/04/2012 Duration: 17minDr. Charles Rudin from Johns Hopkins covers the work from the Lung Cancer Mutation Consortium that identified a wide range of molecular markers in patients with lung adenocarcinoma.
-
Lung Cancer Highlights in 2011: Question and Answer Session with Dr. Jared Weiss (audio)
28/03/2012 Duration: 18minQ and A session with Dr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, about highlights in lung cancer in 2011.
-
Lung Cancer Highlights in 2011: Lung Cancer screening and Treating Advanced Lung Cancer in the Elderly (audio)
21/03/2012 Duration: 13minDr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, here describing evidence supporting lung cancer screening by chest CT, as well as evidence on how best to treat elderly patients with advanced lung cancer.
-
Lung Cancer Highlights in 2011: ALK and New Molecular Targets (audio)
18/03/2012 Duration: 08minDr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, with this podcast focusing on ALK rearrangements and new molecular targets in lung cancer.
-
-
Lung Cancer Highlights in 2011: The EGFR Axis (audio)
14/03/2012 Duration: 11minDr. Jared Weiss, Medical Oncologist at UNC-Chapel Hill, reviews lung cancer highlights in 2011, focusing here on treatments focusing on the EGFR axis.
-
Tips and Tools for Smoking Cessation, by Dr. Mark Millard (audio)
10/03/2012 Duration: 27minDr. Mark Millard, Pulmonologist at Baylor University, describes how to approach smoking cessation and a range of tools for helping smokers who are motivated to quit.
-
A History of Tobacco and the Rise of Lung Cancer, by Dr. Mark Millard (audio)
02/01/2012 Duration: 20minDr. Mark Millard, Pulmonologist at Baylor University, reviews the history of tobacco in North America, early research leading to the association of tobacco with lung cancer, and a discussion of how lung cancer prevalence follows patterns of tobacco use.
-
Challenging Cases in Lung Cancer: Acquired Resistance to EGFR TKI Therapy in a Patient with an Activating EGFR Mutation (audio)
16/12/2011 Duration: 28minCase-based discussion with multiple lung cancer experts on optimal treatment of a patient with advanced lung adenocarcinoma, EGFR mutation, & now acquired resistance to EGFR TKI after very good prior response.
-
Detection and Work-Up of Lung Nodules, by David Yankelevitz (audio)
04/12/2011 Duration: 33minDr. David Yankelevitz, Professor of Radiology at Mount Sinai Medical Center in New York City, reviews technical advances in CT screening for lung nodules, features suggesting whether a nodule is benign or malignant, and the CT-guided biopsy procedure.